問卷

TPIDB > Principal Investigator

Principal Investigator


E-DA Hospital (在職)

Digestive System Department

更新時間:2023-09-19

許筌淵
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2011-01-01 - 2017-12-31

Phase III

A prospective, randomized, double-blind, placebo-controlled, parallel-group, international multicenter phase III trail of PI-88 in the adjuvant treatment of subjects with hepatitis virus related hepatocellular
  • Condition/Disease

    Postoperative adjuvant therapy for hepatitis virus-related liver cancer

  • Test Drug

    PI-88 or matching placebo

Participate Sites
9Sites

Terminated9Sites